Registration Fee Other Information Registration Fee includes continuing education, seminars, materials, breaks, and lunch. A late fee will be applied if the fees are sent after 6/5 for Flatwoods. For more information, contact Michael Kurilla, M.Ed., CE Program Specialist, at (304) 293-5103 or [email protected], or Dr. Ginger Scott, CE Director at (304)293-1553 or at [email protected]. Visit us on the web at http://pharmacy.hsc.wvu.edu/ce/Live-Programs. All Day - 6 hr CE (circle rate) Pharmacists All Others Fee $130 $90 Late Fee $160 $120 Half-Day Only Pharmacists All Others $65 $45 $80 $60 Cancellation Policy Locations 5/15 Barboursville Holiday Inn, 3351 Rt. 60 East, Barboursville, WV 25504 Phone - (304) 733-3338 Directions: I-64 W to EXIT 20A and the hotel will be on the left or EXIT 20 B and the hotel will be on the right. 6/7 Flatwoods Refund minus a $25 fee will be given for cancellations received in writing by 6/5 for Flatwoods. The Office of CE reserves the right to cancel the program due to low registration. If canceled, registrants will be contacted via phone or e-mail. Days Hotel, Sutton Flatwoods, WV 2000 Sutton Lane, Sutton, WV 26601 866-700-7284 or (304) 765-5055 Directions: From I-79, take Exit 67 (Flatwoods Exit). The hotel is at the top of the hill. Register Online Continuing Education Please register and pay online at https://pharmacyce.wvu.edu/user/login. If you cannot register online, please mail or fax the form below to: WVU School of Pharmacy, Office of Continuing Education PO Box 9540 Morgantown, WV 26505 Fax: 304-293-2529 Please Print or Type ___________________________________________________ FIRST NAME MI LAST NAME ___________________________________________________ STREET ADDRESS ___________________________________________________ CITY STATE ZIP ___________________________________________________ PHONE (Home and Work) ___________________________________________________ EMAIL ADDRESS DIETARY RESTRICTIONS Continuing Education Programs for Pharmacists West Virginia University School of Pharmacy (WVUSoP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). The Barboursville and Flatwoods programs are accredited up to a total of 6.0 hours, or 0.6 CEUs for pharmacists. WVUSoP will report your participation in the programs to NABP CPE Monitor within 4 – 6 weeks for all participants who successfully complete each session. Successful completion includes: attending the entire session, signing the attendance sheet and completing an online evaluation form for each session attended. After completing the evaluation form, a statement of credit may be printed on-line, by going to your personal account in our database http://pharmacyce.wvu.edu/user/login. Barboursville Spring Seminar Friday, May 15, 2015 8:00 am – 4:30 pm Holiday Inn, Barboursville, WV 3 hrs. live Drug Diversion CE, 3hrs. additional live CE Return Service Requested (6 hrs CE) ______ (6 hrs CE) ______ WVU School of Pharmacy Office of Continuing Education PO Box 9540 Morgantown, WV 26506-9540 Barboursville Spring Seminar, May 15 Flatwoods Seminar, June 7 Flatwoods Spring Seminar Sunday, June 7, 2015 8:00 am – 4:30 pm Days Hotel, Flatwoods, WV 3 hrs. live Drug Diversion CE, 3hrs. additional live CE Program Description Programs are designed for pharmacists in all practice settings. The Barboursville Seminar will focus on drug diversion updates, West Virginia law update, and Medication Therapy Management. The Flatwoods Seminar will focus on drug diversion updates, new therapies for diabetes management, and Immunization updates. Agenda May 15, 2015 – Barboursville Seminar 8:00am Registration and Refreshments 8:55am Welcome/Announcements 9:00am *Updates in Prescription Drug Diversion, Substance Use Disorders, and Pain Management (Knowledgebased) Michael O’Neil, PharmD ACPE UPN 0072-0000-15-023-L03-P 10:30am Break 10:45am Resume Drug Diversion Presentation 12:15pm Lunch 1:15pm *West Virginia Pharmacy Law Update: 2015 (Knowledge-based) David E. Potters, JD ACPE UPN 0072-0000-15-035-L03-P 2:45pm Break 3:00pm Optimizing the Pharmacist's Role in Patient Care through MTM (Application Based) Ashleigh Barrickman, PharmD ACPE UAN 0072-0000-15-038-L04-P 4:30pm Questions and Conclusion *These sessions were originally presented on 4/26/2015 in Vienna, WV. If you attended one of these sessions, additional credit will not be awarded. June 7 – Flatwoods Seminar 8:00am Registration and Refreshments 8:55am Welcome/Announcements 9:00am *Updates in Prescription Drug Diversion, Substance Use Disorders, and Pain Management (Knowledgebased) Michael O’Neil, PharmD ACPE UPN 0072-0000-15-023-L03-P 10:30am Break 10:45am Resume Drug Diversion Presentation 12:15pm Lunch 1:15pm New Therapies for the Management of Diabetes How Sweet It Is! Charles D. Ponte, BSc, PharmD, DPNAP, FAADE, FAPhA, FASHP, FCCP ACPE UAN 0072-0000-15-039-L01-P 2:45pm Break 3:00pm **A Shot of Prevention: An Update on Current Vaccination Recommendations (Knowledge-based) Dani Dolin, PharmD, CDE, CPT ACPE UPN 0072-0000-15-032-L01-P 4:30pm Questions and Conclusion *This session was originally presented on 4/26/2015 in Vienna, WV, and 5/15/2015 in Barboursville, WV, and 5/17/2015 in Wheeling, WV. If you attended one of these sessions, additional credit will not be awarded. **This session was originally presented on 5/1/2015 in Morgantown, WV. If you attended this session, additional credit will not be awarded. Learning Objectives Updates in Prescription Drug Diversion, Substance Use Disorders, and Pain Management • Discuss what comprises drug diversion, including West Virginia statistics on prescription drug abuse and resulting deaths. • State the epidemiology of chronic pain and misuse of opioids. • Describe the indicators for opioids in chronic pain treatment including general characteristics, toxicities, and drug interactions. • Outline patient evaluation and risk assessment and tools to assess risk and monitor benefits. • Explain the initiation and ongoing-management of chronic pain in patients treated with opioid based therapies. • Discuss a case study of a patient with chronic pain. • Identify diversion and drug seeking behaviors and tactics. • State best practice methods for working with patients, prescribers, and law enforcement concerning patients suspected of drug seeking behavior and diversion. • Give examples of compliance with controlled substances laws. • Identify registration with and use of the West Virginia Controlled Substances Monitoring Program established in West Virginia Code 60A-9-1. Barboursville West Virginia Pharmacy Law Update: 2015 (Knowledge Based) • Discuss laws passed by the 2015 WV Legislature related to pharmacy practice. • Identify the expansion in types of immunizations given by West Virginia pharmacists. • Discuss federal changes for compounding for prescriptions and for 503b outsourcing facilities. Optimizing the Pharmacist's Role in Patient Care through MTM– (Application-based) • Define medication therapy management. • Describe the components of an MTM session. • Explain the goals of an effective MTM session. • Define the benefits of MTM. • Identify barriers to providing MTM in a community pharmacy setting. • Develop strategies for overcoming barriers to MTM. • Assess medication profiles and develop medicationaction plans for patients. Flatwoods New Therapies for the Management of Diabetes - How Sweet It Is! • Describe the changing local and national landscape of diabetes mellitus. • Describe the major characteristics of the metabolic syndrome and its association with cardiovascular risk and diabetes. • Discuss the new incretin-based therapies and their role in the management of diabetes. • Describe the role of the SGLT 2 inhibitors in the management of type 2 diabetes. A Shot of Prevention: An Update on Current Vaccination Recommendations • Compare the available influenza vaccinations and determine how to select the most appropriate vaccine. • Discuss similarities and differences between the pneumococcal polysaccharide and conjugate vaccines. • State the recommendations for tetanus-containing vaccines in adults including target population and revaccination. • Discuss meningococcal vaccines and administration. Faculty Barboursville Michael O’Neil, PharmD Professor of Pharmacy Practice South College School of Pharmacy Knoxville, TN David E. Potters, JD Executive Director and General Counsel WV Board of Pharmacy Charleston, WV Ashleigh Barrickman, PharmD Pharmacist in Charge (PIC) White Hall Pharmacy Fairmont, WV Flatwoods Michael O’Neil, PharmD Professor of Pharmacy Practice South College School of Pharmacy Knoxville, TN Charles D. Ponte, BSc, PharmD, DPNAP, FAADE, FAPhA, FASHP, FCCP Professor of Clinical Pharmacy and Family Medicine West Virginia University Robert C. Byrd Health Sciences Center Schools of Pharmacy and Medicine Morgantown, WV Dani Dolin, PharmD, CDE, CPT Clinical Pharmacist Morgantown, WV
© Copyright 2024